ABSTRACT The use of MALDI mass spectrometry for the analysis of carbohydrates and glycoconjugates is a well‐established technique and this comprehensive review is the twelfth update of the original article published in 1999 and brings coverage of the literature to the end of 2024.
David J. Harvey
wiley +1 more source
A <i>Ganoderma lucidum</i> Polysaccharide-Modified Nanoadjuvant Elicits Potent Cellular Immunity for Hepatitis B Vaccine. [PDF]
Zhai Z, You J, Liu X.
europepmc +1 more source
Proteoforms in Disease: Biomedical Applications of Top‐Down Proteomics
ABSTRACT The proteome is a dynamic landscape of proteoforms arising from genetic mutations, alternative splicing, and post‐translational modifications (PTMs), which collectively drive biological function and disease phenotypes. Mass spectrometry (MS)‐based proteomics has emerged as an essential technique for elucidating this molecular complexity ...
Holden T. Rogers +5 more
wiley +1 more source
Risk of Hepatitis B Reactivation Following Corticosteroids for Tuberculous Meningitis. [PDF]
Donovan J +12 more
europepmc +1 more source
Lupus Nephritis Exhibiting a Membranoproliferative Pattern in Primary Myelofibrosis: A Diagnostic Challenge of Occult SLE. [PDF]
Alem A +3 more
europepmc +1 more source
Characteristics of occult hepatitis B infection among pregnant women in the Center Region of Cameroon: rationale for universal administration of hepatitis B birth dose vaccine. [PDF]
Ondigui JN +16 more
europepmc +1 more source
Paraneoplastic Opsoclonus Without Myoclonus Secondary to High-Grade Serous Carcinoma in an Adult. [PDF]
Bowman C, Mustafa I.
europepmc +1 more source
Interferon-induced interstitial lung disease: a rare adverse effect induced by pegylated interferon-alpha in a patient with chronic hepatitis B-case report. [PDF]
Yu H +5 more
europepmc +1 more source
Emerging Serological Biomarkers for Autoimmune Hepatitis. [PDF]
Abe K, Wada J, Ohira H.
europepmc +1 more source
Hepatitis C Virus Evasion Mechanisms from Neutralizing Antibodies [PDF]
Hepatitis C virus (HCV) represents a major public health problem, affecting 3% of the world’s population. The majority of infected individuals develop chronic hepatitis, which can progress to cirrhosis and hepatocellular carcinoma.
Arvind H Patel, Allan G N Angus
exaly +2 more sources

